Search research articles
Contact Us
Filters
Showing results (31-40 of 94) with videos related to
Page
of 10
Sort By:
Journal of Cutaneous Medicine and Surgery
|
September 17, 2016
Review of Systemic Treatment Options for Adult Atopic Dermatitis
Melinda Gooderham, Charles W Lynde, Kim Papp, et al.
Dermatology and Therapy
|
November 15, 2025
Matching-Adjusted Indirect Comparison of the Efficacy of Delgocitinib Cream and Dupilumab in the Treatment of Moderate to Severe Atopic Hand Eczema
David Cohen, Anthony Bewley, Andreas Wollenberg, et al.
Dermatology and Therapy
|
June 27, 2026
Abrocitinib Achieves Early and Complete/Near-Complete Skin Clearance Plus Itch-Free State in Atopic Dermatitis: Phase 3 Pooled Post Hoc Analysis
Stephen Weidinger, Kristian Reich, Naiem Issa, et al.
Dermatology and Therapy
|
November 12, 2021
Efficacy of Dupilumab in Atopic Dermatitis: The Patient's Perspective
Marjolein de Bruin-Weller, Joseph F Merola, Chih-Ho Hong, et al.
Dermatology and Therapy
|
July 14, 2026
Pushing the Boundaries of Topical Therapy in Patients with Atopic Dermatitis: A Review of Baseline Disease Severity and Burden in Clinical Trials
Melinda J Gooderham, H Chih-Ho Hong, Charles Lynde, et al.
Dermatology and Therapy
|
April 25, 2026
Clinical Laboratory Parameters in Adolescents with Moderate-to-Severe Atopic Dermatitis Treated with Tralokinumab Up to Week 52 in the Phase 3 ECZTRA 6 Trial
Amy S Paller, Michael J Cork, H Chih-Ho Hong, et al.
The Journal of Dermatological Treatment
|
April 26, 2021
Efficacy, tolerability, patient usability, and satisfaction with a 2 mL pre-filled syringe containing secukinumab 300 mg in patients with moderate to severe plaque psoriasis: results from the phase 3 randomized, double-blind, placebo-controlled ALLURE study
Bardur Sigurgeirsson, Knut Schäkel, Chih-Ho Hong, et al.
Dermatologic Therapy
|
August 21, 2022
Management of moderate-to-severe plaque psoriasis with biologics: A treat-to-target position paper
Jensen Yeung, Marc Bourcier, Melinda J Gooderham, et al.
Dermatology and Therapy
|
April 25, 2025
Canadian Consensus Guidelines for the Management of Atopic Dermatitis with Topical Therapies
Melinda J Gooderham, H Chih-Ho Hong, Charles Lynde, et al.
Journal of Cutaneous Medicine and Surgery
|
December 15, 2022
Clinical Implications of Targeting the JAK-STAT Pathway in Psoriatic Disease: Emphasis on the TYK2 Pathway
Wei Jing Loo, Irina Turchin, Vimal H Prajapati, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 94) with videos related to
Sort By:
Page
of 10
Journal of Cutaneous Medicine and Surgery
|
September 17, 2016
Review of Systemic Treatment Options for Adult Atopic Dermatitis
Melinda Gooderham, Charles W Lynde, Kim Papp, et al.
Dermatology and Therapy
|
November 15, 2025
Matching-Adjusted Indirect Comparison of the Efficacy of Delgocitinib Cream and Dupilumab in the Treatment of Moderate to Severe Atopic Hand Eczema
David Cohen, Anthony Bewley, Andreas Wollenberg, et al.
Dermatology and Therapy
|
June 27, 2026
Abrocitinib Achieves Early and Complete/Near-Complete Skin Clearance Plus Itch-Free State in Atopic Dermatitis: Phase 3 Pooled Post Hoc Analysis
Stephen Weidinger, Kristian Reich, Naiem Issa, et al.
Dermatology and Therapy
|
November 12, 2021
Efficacy of Dupilumab in Atopic Dermatitis: The Patient's Perspective
Marjolein de Bruin-Weller, Joseph F Merola, Chih-Ho Hong, et al.
Dermatology and Therapy
|
July 14, 2026
Pushing the Boundaries of Topical Therapy in Patients with Atopic Dermatitis: A Review of Baseline Disease Severity and Burden in Clinical Trials
Melinda J Gooderham, H Chih-Ho Hong, Charles Lynde, et al.
Dermatology and Therapy
|
April 25, 2026
Clinical Laboratory Parameters in Adolescents with Moderate-to-Severe Atopic Dermatitis Treated with Tralokinumab Up to Week 52 in the Phase 3 ECZTRA 6 Trial
Amy S Paller, Michael J Cork, H Chih-Ho Hong, et al.
The Journal of Dermatological Treatment
|
April 26, 2021
Efficacy, tolerability, patient usability, and satisfaction with a 2 mL pre-filled syringe containing secukinumab 300 mg in patients with moderate to severe plaque psoriasis: results from the phase 3 randomized, double-blind, placebo-controlled ALLURE study
Bardur Sigurgeirsson, Knut Schäkel, Chih-Ho Hong, et al.
Dermatologic Therapy
|
August 21, 2022
Management of moderate-to-severe plaque psoriasis with biologics: A treat-to-target position paper
Jensen Yeung, Marc Bourcier, Melinda J Gooderham, et al.
Dermatology and Therapy
|
April 25, 2025
Canadian Consensus Guidelines for the Management of Atopic Dermatitis with Topical Therapies
Melinda J Gooderham, H Chih-Ho Hong, Charles Lynde, et al.
Journal of Cutaneous Medicine and Surgery
|
December 15, 2022
Clinical Implications of Targeting the JAK-STAT Pathway in Psoriatic Disease: Emphasis on the TYK2 Pathway
Wei Jing Loo, Irina Turchin, Vimal H Prajapati, et al.
Page
of 10